Our study further confirms the results of the above reports and suggests that suppression of Bcl-1 and Mcl-1 expression by miRNA-15a can increase the sensitivity of CLL cells to fludarabine. The gene discussed is MCL1; the disease is B-cell chronic lymphocytic leukemia.